HR 7032
117th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Prescription drugs
Increasing Transparency in Generic Drug Applications Act of 2022
Introduced: March 9, 2022
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2022
Referred to the Subcommittee on Health.
Mar 9, 2022
Referred to the House Committee on Energy and Commerce.
Mar 9, 2022
Introduced in House
Plain-English summary
Increasing Transparency in Generic Drug Applications Act of 2022
This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1